A detailed history of Guggenheim Capital LLC transactions in Quantum Si Inc stock. As of the latest transaction made, Guggenheim Capital LLC holds 242,454 shares of QSI stock, worth $315,190. This represents 0.0% of its overall portfolio holdings.

Number of Shares
242,454
Previous 253,274 4.27%
Holding current value
$315,190
Previous $265,000 19.62%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$0.82 - $1.22 $8,872 - $13,200
-10,820 Reduced 4.27%
242,454 $213,000
Q2 2024

Aug 14, 2024

SELL
$0.84 - $1.89 $20,617 - $46,390
-24,545 Reduced 8.83%
253,274 $265,000
Q1 2024

May 14, 2024

SELL
$1.43 - $2.23 $16,665 - $25,988
-11,654 Reduced 4.03%
277,819 $547,000
Q4 2023

Feb 14, 2024

SELL
$1.15 - $2.27 $149,376 - $294,857
-129,893 Reduced 30.97%
289,473 $581,000
Q3 2023

Nov 14, 2023

SELL
$1.6 - $3.89 $463,470 - $1.13 Million
-289,669 Reduced 40.85%
419,366 $696,000
Q2 2023

Aug 11, 2023

BUY
$1.38 - $1.83 $126,906 - $168,288
91,961 Added 14.9%
709,035 $1.27 Million
Q1 2023

May 10, 2023

BUY
$1.59 - $2.58 $7,288 - $11,826
4,584 Added 0.75%
617,074 $1.09 Million
Q4 2022

Feb 14, 2023

SELL
$1.82 - $3.27 $120,533 - $216,562
-66,227 Reduced 9.76%
612,490 $1.12 Million
Q3 2022

Nov 14, 2022

SELL
$0.74 - $4.35 $13,205 - $77,625
-17,845 Reduced 2.56%
678,717 $1.87 Million
Q2 2022

Aug 15, 2022

SELL
$2.32 - $4.9 $63,022 - $133,108
-27,165 Reduced 3.75%
696,562 $1.62 Million
Q1 2022

May 16, 2022

SELL
$3.86 - $8.22 $82,766 - $176,253
-21,442 Reduced 2.88%
723,727 $3.39 Million
Q4 2021

Feb 14, 2022

BUY
$5.65 - $8.75 $868,467 - $1.34 Million
153,711 Added 25.99%
745,169 $5.86 Million
Q3 2021

Nov 15, 2021

BUY
$7.97 - $13.56 $4.71 Million - $8.02 Million
591,458 New
591,458 $4.93 Million

Others Institutions Holding QSI

About Quantum-Si Inc


  • Ticker QSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 119,433,000
  • Market Cap $155M
  • Description
  • Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guil...
More about QSI
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.